The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...

Monoclonal antibody (mAb): Originally, mAbs were antibodies produced from a single B lymphocyte. Genetic manipulation now allows genes from multiple sources of B lymphocytes (e.g., mouse and human ...

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

The Biden administration's FDA "seemed to be inert" on the issue, and even "obstructionist," after Congress removed mandatory animal testing, longtime group leader says. Bill to ban research funding ...

A super-resolution microscopy technique offers an unparalleled glimpse into how monoclonal antibodies bind to their targets on cancer cells to induce cell death.

PETA and other animal advocacy groups have praised the Trump administration for recent announcements to phase out animal ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Sanofi (NASDAQ:SNY) announced Tuesday that its TIDE-Asthma Phase 2 study for its T-cell-depleting monoclonal antibody ...

A key theme at the AD/PD 2025 has been the safety profile of DMTs, focusing on the issue of ARIA, a significant side effect ...

The randomized, double-blind, placebo-controlled trial aims to assess the safety, tolerability, and efficacy of intranasal foralumab in patients with na-SPMS, a form of multiple sclerosis (MS) ...